Picture of Calcimedica logo

CALC — Calcimedica News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Graybug Vision Inc expected to post a loss of 37 cents a share - Earnings Preview

* Graybug Vision Inc  GRAY.OQ   GRAY.O  is expected to show no
change in quarterly revenue when it reports  results on November
10 (estimated). 
​* Refinitiv's mean analyst estimate for Graybug Vision Inc is
for a loss of 37 cents per share. For the same quarter last
year, the company reported a loss of $2.52 per share.
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 1 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Graybug Vision
Inc is $4.5​, about 27.6% above​ its last closing price
of $3.26. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 30 2021  -0.47       -0.47      -0.36     Beat    23.1
 Mar. 31 2021  -0.44       -0.44      -0.54     Missed  -22.7
 Dec. 31 2020  -0.40       -0.40      -1.38     Missed  -240.7
                                                        ​
 Sep. 30 2020  -0.56       -0.56      -2.52     Missed  -350
 ​​                                                     
                                                        ​
 This summary was machine generated November 9 at 03:07 GMT.  All
figures in US dollars unless otherwise stated

Recent news on Calcimedica

See all news